Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019
Research

Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012–2013

Najwa Ouhoummane, Eric Tchouaket, Anne-Marie Lowe, Ann Fortin, Dahlia Kairy, Anne Vibien, Jessica Kovitz-Lensch, Terry-Nan Tannenbaum1, and François MilordComments to Author 
Author affiliations: Institut National de Santé Publique du Quebec, Quebec City, Canada (N. Ouhoummane, A. Fortin, F. Milord); Université du Quebec en Outaouais, Gatineau, Quebec, Canada (E. Tchouaket); Public Health Agency of Canada, Montreal, Quebec, Canada (A.-M. Lowe); Université de Montreal, Montreal, Quebec, Canada (D. Kairy); Centre de Recherche Interdisciplinaire en Réadaptation du Montreal Métropolitain, Montreal (D. Kairy); Centre Intégré de Santé et de Services Sociaux de la Montérégie Est-Hôpital Honoré Mercier, St.-Hyacinthe, Quebec, Canada (A. Vibien, J. Kovitz-Lensch); Institut National de Santé Publique de Montreal, Montreal (T.-N. Tannenbaum); Université de Sherbrooke, Sherbrooke, Quebec, Canada (F. Milord)

Main Article

Table 7

Median economic costs of WNV diseases per patient by clinical syndrome, Quebec, Canada, 2012–2013*

Cost Disease, no. patients; cost (IQR)
WNF WNM WNE†
Hospitalization 5; 5,604 (2,295–5,604) 17; 2,372 (2,295–5,604) 47; 15,839 (7,603–27,931)
ED visit 12; 110 (110–110) 18; 110 (110–110) 48; 110 (110–110)
Inpatient rehabilitation 0, 0 1; 18,340 (18,340–18,340) 6; 39,301 (26,200–78,602)
Outpatient readaptation‡ 2; 890 (200–1,580) 3; 632 (100–4,462) 7; 3,792 (2,540–4,661)
Physician visit§ 15; 80 (42–160) 13; 231 (126–280) 29; 111 (71–152)
Additional¶ 5; 100 (100–340) 12; 100 (100–125) 35; 100 (100–115)
Indirect (absence from work)# 7; 1,268 (961–5,434) 16; 3,200 (1,259–9,418) 18; 4,500 (3,000–8,653)

*Costs are in Canadian dollars. Median costs are expressed as per-patient cost on the basis of participants who incurred costs in each category (excluding patients with 0 costs). ED, emergency department; IQR, interquartile range; WNE, West Nile encephalitis; WNF, West Nile fever; WNM, West Nile meningitis; WNV, West Nile virus.
†Includes WNE (n = 28), meningoencephalitis (n = 18), and acute flaccid paralysis (n = 2).
‡Includes physiotherapy, occupational therapy, speech therapy, and home care costs.
§Includes primary care physician and neurologist consultations costs.
¶Includes medical equipment purchase, recruitment for household chores costs, and other personal expenses.
#Includes participants, and families, missed work costs.

Main Article

1Deceased.

Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external